Exploring the Therapeutic Mechanism of Baduanjin in the Treatment of Elderly Stable Angina Pectoris Based on the Gut Microbiota-lipid Metabolism Spectrum: Study Protocol for a Randomized Controlled Trial

Overview

Journal Front Public Health

Specialty Public Health

Date 2022 Nov 17

PMID 36388277

Authors

Xiao Jin

Shengjie Yang

Jing Lu

Yujuan Li

Yixi Zhao

Dan Li

Xinyue Wang

Longtao Liu

Min Wu

Affiliations

Soon will be listed here.

Abstract

Importance: Stable angina pectoris (SAP) often occurs in the elderly and is relatively stable for 1-3 months; however, if patients do not receive effective treatment, life-threatening acute myocardial infarction could occur. Patients with different clinical types of coronary heart disease have different intestinal flora. Baduanjin, a traditional Chinese Qigong, has been used as adjuvant therapy to improve the symptoms of patients with SAP.

Objective: To determine the effect of Baduanjin exercise on the symptoms of patients with SAP and the intestinal flora, explore the action links and targets of Baduanjin intervention in elderly patients with SAP, and explain its mechanism.

Design: A single-center, single-blind, randomized controlled trial. Patients and outcome assessors were blinded to group allocation.

Setting: The trial will be conducted at Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

Participants: One hundred and eighty patients aged 60 to 80 years with stable angina pectoris (I-III) were intervened for 8 weeks and followed up for half a year.

Interventions: Among the screened patients, 180 patients will be randomly assigned to either the Baduanjin or the control group at a 1:1 ratio (exercise duration: for 3-5 times a week, for 8 weeks) of moderate-intensity Baduanjin or free activities.

Main And Secondary Results: The main result is the total effective rate for angina pectoris symptoms; secondary results include the duration of angina pectoris, number of angina pectoris episodes per week, nitroglycerin consumption, nitroglycerin reduction rate, Seattle angina score (SAQ), quality of life (SF-36),Traditional Chinese Medicine (TCM) syndrome scores, electrocardiogram (ECG) changes, blood lipid serum hypersensitive C-reactive protein levels, intestinal flora changes, serum changes in the intestinal flora metabolite Trimetlylamine oxide (TMAO), and non-targeted liposome detection. Adverse events will be recorded throughout the experiment, and the data will be analyzed by researchers who did not know about the assignment.

Discussion: This study provides compelling evidence for at-home use of Baduanjin exercise to relieve SAP-associated symptoms.

Trial Registration: This study was approved by the ethics committee of Guang'anmen Hospital of China Academy of Chinese Medical Sciences (2022-121-KY). The trial has been registered in Chinese Clinical Trial Registration Center (ChiCTR2200062450).

Citing Articles

Mediating role of gut microbiota on Baduanjin for cognitive function in community-dwelling older adults with mild cognitive impairment: a study protocol for a cluster randomised controlled trial.

Sun L, Geng Q, Zheng G BMJ Open. 2024; 14(11):e087684.

PMID: 39578030 PMC: 11590836. DOI: 10.1136/bmjopen-2024-087684.

References

Koh T . Baduanjin -- an ancient Chinese exercise. Am J Chin Med. 1982; 10(1-4):14-21. DOI: 10.1142/S0192415X8200004X. View

Schutzer K, Graves B . Barriers and motivations to exercise in older adults. Prev Med. 2004; 39(5):1056-61. DOI: 10.1016/j.ypmed.2004.04.003. View

Brazier J, Harper R, Jones N, OCathain A, Thomas K, Usherwood T . Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992; 305(6846):160-4. PMC: 1883187. DOI: 10.1136/bmj.305.6846.160. View

Liu L, Luo F . Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients. Front Biosci (Landmark Ed). 2022; 27(3):100. DOI: 10.31083/j.fbl2703100. View

. Corrigendum to: 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019; 41(44):4242. DOI: 10.1093/eurheartj/ehz825. View

Montalescot G, Sechtem U, Andreotti F, Arden C, Budaj A, Bugiardini R . 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34(38):2949-3003. DOI: 10.1093/eurheartj/eht296. View

Balady G, Ades P, Bittner V, Franklin B, Gordon N, Thomas R . Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation. 2011; 124(25):2951-60. DOI: 10.1161/CIR.0b013e31823b21e2. View

Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010; 152(11):726-32. DOI: 10.7326/0003-4819-152-11-201006010-00232. View

Nelson M, Rejeski W, Blair S, Duncan P, Judge J, King A . Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007; 39(8):1435-45. DOI: 10.1249/mss.0b013e3180616aa2. View

10.

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted.... Eur Heart J. 2012; 33(13):1635-701. DOI: 10.1093/eurheartj/ehs092. View

11.

Xiong X, Wang P, Li S, Zhang Y, Li X . Effect of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials. Maturitas. 2015; 80(4):370-8. DOI: 10.1016/j.maturitas.2015.01.002. View

12.

Bao X, Qiu Q, Shao Y, Quiben M, Liu H . Effect of Sitting Ba-Duan-Jin Exercises on Balance and Quality of Life Among Older Adults: A Preliminary Study. Rehabil Nurs. 2019; 45(5):271-278. DOI: 10.1097/rnj.0000000000000219. View

13.

Ades P, Waldmann M, Polk D, Coflesky J . Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years. Am J Cardiol. 1992; 69(17):1422-5. DOI: 10.1016/0002-9149(92)90894-5. View

14.

Smith Jr S, Benjamin E, Bonow R, Braun L, Creager M, Franklin B . AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011; 124(22):2458-73. DOI: 10.1161/CIR.0b013e318235eb4d. View

15.

Dong Z, Zhang J, Luo Y, Zhao M, Cai J, Cheng S . The correlation between trimethylamine N-oxide, lipoprotein ratios, and conventional lipid parameters in patients with unstable angina pectoris. Biosci Rep. 2020; 40(1). PMC: 6960062. DOI: 10.1042/BSR20192657. View

16.

Wang J, Xiong X . Evidence-based chinese medicine for hypertension. Evid Based Complement Alternat Med. 2013; 2013:978398. PMC: 3686073. DOI: 10.1155/2013/978398. View

17.

Mei L, Chen Q, Ge L, Zheng G, Chen J . Systematic review of chinese traditional exercise baduanjin modulating the blood lipid metabolism. Evid Based Complement Alternat Med. 2013; 2012:282131. PMC: 3524626. DOI: 10.1155/2012/282131. View

18.

Sun M, Miao Y, Jin M, Dong Y, Liu S, Wang M . Effect and Safety of Guanxinning Tablet () for Stable Angina Pectoris Patients with Xin (Heart)-Blood Stagnation Syndrome: A Randomized, Multicenter, Placebo-Controlled Trial. Chin J Integr Med. 2019; 25(9):684-690. DOI: 10.1007/s11655-019-3069-8. View

19.

Li Y, Zhang L, Lv S, Wang X, Zhang J, Tian X . Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial. BMC Complement Altern Med. 2019; 19(1):363. PMC: 6907120. DOI: 10.1186/s12906-019-2778-z. View

20.

Anderson L, Thompson D, Oldridge N, Zwisler A, Rees K, Martin N . Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016; (1):CD001800. PMC: 6491180. DOI: 10.1002/14651858.CD001800.pub3. View